Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels - Jaspers, Tessa C. C.; Meijer, Charlotte E.; Vleming, Louis Jean; Franssen, Casper F. M.; Diepstraten, Jeroen; Lukens, Michael V.; van den Bemt, Patricia M. L. A.; Maat, Barbara; Khorsand, Nakisa; Touw, Daniël J.; Koomen, Jeroen V. (Clinical pharmacokinetics, 2022)
Keywords: Administration, Intravenous; Anticoagulants; Anticoagulants - pharmacology; Blood clots; Clinical medicine; Datasets; Dialysate; Dialyzers; Factor Xa Inhibitors - therapeutic use; Hemodialysis; Humans; Internal Medicine; Laboratories; Medical ethics; Medicine; Medicine & Public Health; Nadroparin - pharmacology; Nadroparin - therapeutic use; Original; Original Research Article; Patients; Pharmacodynamics; Pharmacology/Toxicology; Pharmacotherapy; Renal Dialysis; Software; Venous Thromboembolism - drug therapy; Venous Thromboembolism - etiology; Venous Thromboembolism - prevention & control; Netherlands; Germany